Jaguar Health Spikes 50% After Subsidiary Receives Preclinical Services From NIAID

Jaguar Health shares have spiked higher after the company announced its subsidiary, Napo Pharmaceuticals, will receive preclinical services from the federal government to support the development of the drug lechlemer that treats cholera.